86 related articles for article (PubMed ID: 20648208)
1. Opioid-sparing effect of intravenous outpatient ketamine infusions appears short-lived in chronic-pain patients with high opioid requirements.
Kapural L; Kapural M; Bensitel T; Sessler DI
Pain Physician; 2010; 13(4):389-94. PubMed ID: 20648208
[TBL] [Abstract][Full Text] [Related]
2. Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series.
Lauritsen C; Mazuera S; Lipton RB; Ashina S
J Headache Pain; 2016 Dec; 17(1):106. PubMed ID: 27878523
[TBL] [Abstract][Full Text] [Related]
3. The use of ketamine infusion to dramatically reduce opioid requirements in a patient whose high-dose intrathecal opioid pump was inadvertently cut during surgery.
McDonald WM; Wilkinson MM; Jain A; Cohen SP
Pain Pract; 2023 Nov; 23(8):978-981. PubMed ID: 37312629
[TBL] [Abstract][Full Text] [Related]
4. Chronic Opioid Therapy Modifies QST Changes After Ketamine Infusion in Chronic Pain Patients.
Maher DP; Zhang Y; Ahmed S; Doshi T; Malarick C; Stabach K; Mao J; Chen L
J Pain; 2017 Dec; 18(12):1468-1475. PubMed ID: 28802882
[TBL] [Abstract][Full Text] [Related]
5. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain.
Sullivan MD; Von Korff M; Banta-Green C; Merrill JO; Saunders K
Pain; 2010 May; 149(2):345-353. PubMed ID: 20334974
[TBL] [Abstract][Full Text] [Related]
6. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.
Cohen SP; Bhatia A; Buvanendran A; Schwenk ES; Wasan AD; Hurley RW; Viscusi ER; Narouze S; Davis FN; Ritchie EC; Lubenow TR; Hooten WM
Reg Anesth Pain Med; 2018 Jul; 43(5):521-546. PubMed ID: 29870458
[TBL] [Abstract][Full Text] [Related]
7. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.
Schwenk ES; Viscusi ER; Buvanendran A; Hurley RW; Wasan AD; Narouze S; Bhatia A; Davis FN; Hooten WM; Cohen SP
Reg Anesth Pain Med; 2018 Jul; 43(5):456-466. PubMed ID: 29870457
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous application of lidocaine and ketamine during ambulatory infusion therapy: a retrospective analysis.
Striebel J; Ruppen W; Schneider T
Pain Manag; 2023 Sep; 13(9):539-553. PubMed ID: 37850330
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of 7- to 14-day subanesthetic ketamine infusions for chronic pain on standardized psychiatric measures.
Marzoughi S; Ripsman D; Ong M
Pain Manag; 2023 Sep; 13(9):529-538. PubMed ID: 37656045
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Ketamine for Cancer Pain Management, Including Flares During the COVID-19 Pandemic: A Retrospective Study.
Oh D; Haffey P; Patel A; Gulati A
Pain Med; 2021 Jul; 22(7):1642-1650. PubMed ID: 34086927
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the Influence of IV Ketamine on Postoperative Opioid Use for Surgical Patients at a Tertiary Care Centre.
Porter D; Yamashita S; Van Der Vyver M; Marchesano R
Can J Hosp Pharm; 2023; 76(1):48-55. PubMed ID: 36683660
[TBL] [Abstract][Full Text] [Related]
12. Outpatient Ketamine Infusions for the Treatment of Fibromyalgia and Chronic Pain Syndrome: A Case Report.
Sharma S; Gupta R
Cureus; 2023 Sep; 15(9):e44909. PubMed ID: 37814751
[TBL] [Abstract][Full Text] [Related]
13. A dose-escalation clinical trial of intranasal ketamine for uncontrolled cancer-related pain.
Singh V; Gillespie TW; Lane O; Spektor B; Zarrabi AJ; Egan K; Curseen K; Tsvetkova M; Beumer JH; Sniecinski R; Shteamer JW; Switchenko J; Harvey RD
Pharmacotherapy; 2022 Apr; 42(4):298-310. PubMed ID: 35146776
[TBL] [Abstract][Full Text] [Related]
14. Low-dose ketamine infusion to facilitate opioid tapering in chronic non-cancer pain with opioid-use disorder: a historical cohort study.
Elyn A; Roussin A; Lestrade C; Franchitto N; Jullian B; Cantagrel N
Reg Anesth Pain Med; 2024 Jun; ():. PubMed ID: 38499357
[TBL] [Abstract][Full Text] [Related]
15. Ketamine infusion for patients receiving extracorporeal membrane oxygenation support: a case series.
Tellor B; Shin N; Graetz TJ; Avidan MS
F1000Res; 2015; 4():16. PubMed ID: 26309726
[TBL] [Abstract][Full Text] [Related]
16. Retrospective review of the efficacy for sublingual ketamine in the treatment of chronic low back pain defined by a cause and central functional pain symptom focused clinical model.
Johnson D; Feng L; Johnson C
Disabil Rehabil; 2024 May; 46(10):2117-2124. PubMed ID: 37259521
[TBL] [Abstract][Full Text] [Related]
17. Ketamine for Pain in Sickle Cell Disease Reduces Opioid Usage.
Onyebuchi CO; Chumpitazi CE; Placencia JL; Jackson AN; Jones JL; Torres L; Tubman VN
J Pain Symptom Manage; 2024 Mar; 67(3):e169-e175. PubMed ID: 38000561
[TBL] [Abstract][Full Text] [Related]
18. [S3 guideline of AWMF--long-term administration of opioids in non-tumor pain].
Z Orthop Unfall; 2010 Mar; 148(2):132-3. PubMed ID: 20376751
[No Abstract] [Full Text] [Related]
19. Low-dose ketamine infusions for chronic pain management: Does this qualify as evidence-based practice?
Griffiths HM
Br J Pain; 2023 Oct; 17(5):457-467. PubMed ID: 38107756
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors of success and failure for intravenous ketamine therapy in patients suffering from chronic neuropathic pain.
Gargori NMB; Alahwal H; Vacheron CH; Alam FMA
Saudi J Anaesth; 2023; 17(3):340-348. PubMed ID: 37601528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
